Healthcare & Pharmaceuticals Industry Press Releases

Published on March 3, 2021 - 14:07 GMT

Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr

SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of laboratory developed tests (LDTs) based on Saphyr. The DEX …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 3, 2021 - 14:00 GMT

Philips and Disney join forces to improve the healthcare experience of children

March 3, 2021 Philips partners with European Hospitals to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children’s patient experience during MRI exams Study will explore the effects and use …

Distribution channels:

Published on March 3, 2021 - 14:00 GMT

Ovia Health Partners with March of Dimes to Provide Dynamic Support for Parents in the NICU

BOSTON, March 03, 2021 (GLOBE NEWSWIRE) -- Ovia Health, the most trusted family health digital platform, today announced a new strategic partnership with March of Dimes, the nation’s leader in the fight for the health of all moms and babies, to provide …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 3, 2021 - 14:00 GMT

Indegene and ConTIPI Medical Ltd partner to bring innovative disposable non-surgical device to market to help women suffering from ...

PRINCETON, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 3, 2021 - 14:00 GMT

Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

SAN FRANCISCO and LONDON, March 03, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 3, 2021 - 13:48 GMT

PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Stock

SPARTA, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform designed to …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 3, 2021 - 13:45 GMT

The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots ...

London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings. The digitization of data and advances in …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 3, 2021 - 13:37 GMT

Skye Bioscience to Present at H.C. Wainwright Global Life Sciences Conference

San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases …

Distribution channels:

Published on March 3, 2021 - 13:35 GMT

Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

PHILADELPHIA, PA, March 03, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on March 3, 2021 - 13:31 GMT

Ultragenyx to Present at Barclays Global Healthcare Conference

NOVATO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today …

Distribution channels: